Vanda Pharmaceuticals (VNDA) Stock: Buy, Sell, or Hold?
VNDA - Vanda Pharmaceuticals Inc.
$4.05
0.05 (1.25%)
▲
5d:
+0.0%
30d:
-17.52%
90d:
-20.59%
BUY
HIGH Confidence
Analysis Updated: Oct 29, 2026 12:00 AM ET
Earnings: Oct 28, 2026
0d
Get Alerted When VNDA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: VNDA shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: VNDA shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: VNDA is currently trading at $4.05, which is considered oversold relative to its 30-day fair value range of $4.07 to $4.92.
Technical Outlook: Technically, VNDA is in a strong downtrend. Immediate support is located at $3.79, while resistance sits at $4.64.
Market Sentiment: VNDA scores 94/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $11.50 (+184.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, VNDA is in a strong downtrend. Immediate support is located at $3.79, while resistance sits at $4.64.
Market Sentiment: VNDA scores 94/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $11.50 (+184.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.07 -
$4.92
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (94/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 184.0% below Wall St target ($11.50)
- BULLISH: Bottoming setup score 94/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$4.07 -
$4.92
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.79
Resistance Level
$4.64
Current Trend
Strong Downtrend
Technical data as of
Oct 29, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.23
Wall Street Target
$11.50
(+184.0%)
Revenue Growth (YoY)
-3.9%
Earnings Growth (YoY)
-95.9%
Profit Margin
-127.4%
Share & Embed Analysis
Last updated: October 30, 2026 1:25 AM ET
Data refreshes hourly during market hours. Next update: 2:25 AM
Data refreshes hourly during market hours. Next update: 2:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VNDA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$259 | 65 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 67 BUY |
|
VRTX
Vertex Pharmaceuticals I… |
STRONG BUY
32 analysts |
$571 | 41 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 66 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
